Relationship between IgA vasculitis and prothrombotic risk factors: A prospective, case-control study.

IF 1.1 Q4 RHEUMATOLOGY
Archives of rheumatology Pub Date : 2024-12-12 eCollection Date: 2024-12-01 DOI:10.46497/ArchRheumatol.2024.10711
Cengiz Zeybek, Ahmet Bolat, Orhan Gürsel, Bülent Hacıhamdioğlu, Ahmet Emin Kürekçi
{"title":"Relationship between IgA vasculitis and prothrombotic risk factors: A prospective, case-control study.","authors":"Cengiz Zeybek, Ahmet Bolat, Orhan Gürsel, Bülent Hacıhamdioğlu, Ahmet Emin Kürekçi","doi":"10.46497/ArchRheumatol.2024.10711","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>This study aimed to determine whether there are commonly occurring hematologic causes that may lead to thrombosis in patients recently diagnosed with immunoglobulin A vasculitis (IgAV).</p><p><strong>Patients and methods: </strong>The prospective study enrolled 107 pediatric patients diagnosed with IgAV and 98 healthy age- and sex-matched controls. Patients with IgAV who were treated at a single center between February 2016 and June 2022 were evaluated for the prevalence and clinical relevance of thrombophilic gene mutations and other prothrombotic risk factors, as well as coagulation test indices. The genotypes for common mutations in prothrombin (Pt) G20210A, factor V Leiden (FVL), and methylenetetrahydrofolate reductase (MTHFR) C677T were assessed. The coagulation assays, including Pt time and activated partial thromboplastin time, and the levels of fibrinogen, factor VIII, factor IX, and von Willebrand factor antigen were analyzed. Additionally, the levels of antithrombin, protein C, and free protein S were evaluated during the disease's acute phase before initiation of anti-inflammatory drugs.</p><p><strong>Results: </strong>Seventeen of the 107 IgAV patients were excluded. Consequently, 90 children (36 males, 54 females; mean age: 10.2±3.2 years; range, 3 to 18 years) diagnosed with IgAV and 98 healthy children (45 males, 53 females; mean age: 9.7±3.8 years; range, 2 to 18 years) as a control group were analyzed. A statistical analysis found no significant difference between the groups in terms of indices of coagulation assays and other prothrombotic risk factors (p>0.05). The mutation frequencies of the Pt G20210A, FVL, and MTHFR C677T loci among IgAV patients were not significantly different from the control group (p>0.05).</p><p><strong>Conclusion: </strong>Given there is no predisposition to thrombophilia and IgAV is a form of vasculitis, the cause of thrombosis among patients with IgAV may involve mechanisms related to the inflammationhemostasis cascade.</p>","PeriodicalId":93884,"journal":{"name":"Archives of rheumatology","volume":"39 4","pages":"670-678"},"PeriodicalIF":1.1000,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11883261/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of rheumatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.46497/ArchRheumatol.2024.10711","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: This study aimed to determine whether there are commonly occurring hematologic causes that may lead to thrombosis in patients recently diagnosed with immunoglobulin A vasculitis (IgAV).

Patients and methods: The prospective study enrolled 107 pediatric patients diagnosed with IgAV and 98 healthy age- and sex-matched controls. Patients with IgAV who were treated at a single center between February 2016 and June 2022 were evaluated for the prevalence and clinical relevance of thrombophilic gene mutations and other prothrombotic risk factors, as well as coagulation test indices. The genotypes for common mutations in prothrombin (Pt) G20210A, factor V Leiden (FVL), and methylenetetrahydrofolate reductase (MTHFR) C677T were assessed. The coagulation assays, including Pt time and activated partial thromboplastin time, and the levels of fibrinogen, factor VIII, factor IX, and von Willebrand factor antigen were analyzed. Additionally, the levels of antithrombin, protein C, and free protein S were evaluated during the disease's acute phase before initiation of anti-inflammatory drugs.

Results: Seventeen of the 107 IgAV patients were excluded. Consequently, 90 children (36 males, 54 females; mean age: 10.2±3.2 years; range, 3 to 18 years) diagnosed with IgAV and 98 healthy children (45 males, 53 females; mean age: 9.7±3.8 years; range, 2 to 18 years) as a control group were analyzed. A statistical analysis found no significant difference between the groups in terms of indices of coagulation assays and other prothrombotic risk factors (p>0.05). The mutation frequencies of the Pt G20210A, FVL, and MTHFR C677T loci among IgAV patients were not significantly different from the control group (p>0.05).

Conclusion: Given there is no predisposition to thrombophilia and IgAV is a form of vasculitis, the cause of thrombosis among patients with IgAV may involve mechanisms related to the inflammationhemostasis cascade.

IgA血管炎与血栓形成前危险因素的关系:一项前瞻性病例对照研究。
目的:本研究旨在确定近期诊断为免疫球蛋白A血管炎(IgAV)的患者是否存在常见的血液学原因可能导致血栓形成。患者和方法:这项前瞻性研究纳入了107名诊断为IgAV的儿科患者和98名年龄和性别匹配的健康对照组。在2016年2月至2022年6月期间在单一中心接受治疗的IgAV患者评估了亲血栓基因突变和其他血栓形成前危险因素以及凝血试验指标的患病率和临床相关性。对凝血酶原(Pt) G20210A、Leiden因子(FVL)和亚甲基四氢叶酸还原酶(MTHFR) C677T常见突变的基因型进行了评估。分析凝血试验,包括Pt时间和活化部分凝血活酶时间,以及纤维蛋白原、因子VIII、因子IX和血管性血友病因子抗原的水平。此外,在开始使用抗炎药物之前,在疾病的急性期评估抗凝血酶、蛋白C和游离蛋白S的水平。结果:107例IgAV患者中有17例被排除在外。因此,90名儿童(36名男性,54名女性;平均年龄:10.2±3.2岁;年龄范围3至18岁)和98名健康儿童(男性45名,女性53名;平均年龄9.7±3.8岁;范围为2 ~ 18岁)作为对照组进行分析。经统计学分析,两组间凝血指标及其他血栓形成前危险因素差异无统计学意义(p < 0.05)。IgAV患者中Pt G20210A、FVL、MTHFR C677T位点的突变频率与对照组比较差异无统计学意义(p < 0.05)。结论:鉴于IgAV患者无血栓形成倾向,且IgAV是血管炎的一种形式,IgAV患者血栓形成的原因可能与炎症-止血级联反应有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信